Crowdfunding for Myeloma Research: Is It a Good Idea?

There has been some discussion lately about an alternative method of funding myeloma research known as crowdfunding. Crowdfunding is the act of raising money from a large number of individuals on the internet for a specific project or venture.

Is this something which might be helpful for the myeloma community? Perhaps.

IMF’s Asian Myeloma Network Succeeds in Providing Access to Pomalidomide in Asia

Access to new drugs outside of the US is frequently delayed by several years following FDA approval in the US. For example, lenalidomide (Revlimid®) received US FDA approval in June 2006, yet is still not fully approved and available globally. This lack of access has a significant negative impact for myeloma patients.

Where Do New Drugs Come From?

In preparing for my “Best of ASH 2014” presentation, I noted there were plenty of new drug presentations, but not as many as were presented at the American Society of Hematology (ASH) annual meeting in 2013.

What Causes Myeloma? New Study Suggests Random Mutations Are Important

A new study published in Science magazine and reported in the New York Times this week shows that random mutations in normal tissues are more important than previously thought. The study, conducted by Johns Hopkins Medicine researchers Cristian Tomasetti and Bert Vogelstein, did not analyze myeloma, but developed principles that apply broadly for all cancers.

Life Tips from a Small Greek Island

In a new book, writer Diane Kochilas explores why “the small Greek island of Ikaria is home to some of the healthiest, most vibrant people on earth.” It’s a phenomeno

Pages